Answers are grounded in this paper and cite their sources.
The aim of this study was to assess the association among toxicity, dosimetry of organs-at-risk, and disease progression in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with 177 Lu-DOTATATE.
No takes yet. Share an insight, caveat, or question.
Mileva et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: